{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:55:01Z","timestamp":1786737301360,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijo.ijo_896_20","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T13:06:33Z","timestamp":1597928793000},"page":"1983","source":"Crossref","is-referenced-by-count":4,"title":["Commentary: Rituximab in scleritis"],"prefix":"10.4103","volume":"68","author":[{"given":"Parthopratim","family":"Dutta Majumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.292595-1","first-page":"351","article-title":"Scleritis","author":"Okhravi","year":"2005","journal-title":"SurvOphthalmol"},{"key":"key-10.4103\/0301-4738.292595-2","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4103\/ijo.IJO_2249_19","article-title":"Rituximab therapy combined with methotrexate for severe necrotizing scleritis in a case of granulomatosis with polyangiitis","author":"Murthy","year":"2020","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.292595-3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000486791","article-title":"Cyclophosphamide or rituximab treatment of scleritisand uveitis for patients with granulomatosis with polyangiitis","author":"Ahmed","year":"2019","journal-title":"Ophthalmic Res"},{"key":"key-10.4103\/0301-4738.292595-4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/09273940802331643","article-title":"Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis","author":"Onal","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292595-5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ophtha.2015.01.016","article-title":"Long-term outcomes of rituximab therapy in ocular granulomatosis with polyangiitis: Impact on localized and nonlocalizeddisease","author":"Joshi","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.292595-6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ophtha.2014.04.044","article-title":"Rituximab therapy for refractory scleritis: Results of a phase I\/II dose-ranging, randomized, clinical trial","author":"SuhlerEB,","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.292595-7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/bjo.2008.147157","article-title":"Rituximab for treatment of scleritis associated with rheumatoid arthritis","author":"Chauhan","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292595-8","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/IOP.0000000000000251","article-title":"Idiopathic orbital inflammation associated with necrotizing scleritisand temporal bone inflammation","author":"Kasi","year":"2016","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key-10.4103\/0301-4738.292595-9","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/ard.2004.027128","article-title":"Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab","author":"Ahmadi-Simab","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/0301-4738.292595-10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajo.2015.12.032","article-title":"Rituximab in the treatment of refractory noninfectiousscleritis","author":"Cao","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292595-11","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1111\/j.1755-3768.2011.02127.x","article-title":"Fatal pneumocystis jirovecii pneumonia following immunosuppressive therapy with rituximab and prednisolone for posterior scleritis","author":"Stilling-Vinther","year":"2012","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"key-10.4103\/0301-4738.292595-12","first-page":"90","article-title":"Macular oedema following rituximab infusion in two patients with Wegener's granulomatosis","author":"Bussone","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"key-10.4103\/0301-4738.292595-13","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1080\/09273948.2017.1327602","article-title":"Rituximab induction and maintenance treatment in patients with scleritisand granulomatosis with polyangiitis (Wegener's)","author":"You","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292595-14","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00417-015-3198-5","article-title":"Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's)","author":"Recillas-Gispert","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.292595-15","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24454","article-title":"Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis","author":"Taylor","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0301-4738.292595-16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.autrev.2019.03.001","article-title":"Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients","author":"P\u00e9rez-JacoisteAs\u00edn","year":"2019","journal-title":"Autoimmun Rev"},{"key":"key-10.4103\/0301-4738.292595-17","first-page":"567","article-title":"Necrotising scleritisand peripheral ulcerative keratitis Associated with rheumatoid arthritis treated with rituximab","author":"Hardy","year":"2017","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"key-10.4103\/0301-4738.292595-18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bjo.2007.133173","article-title":"Rituximab for treatment of ocular inflammatory disease: A series of four cases","author":"Kurz","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292595-19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/09273948.2013.788724","article-title":"Rituximab therapy for refractory idiopathic scleritis","author":"Bogdanic-Werner","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292595-20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2169\/internalmedicine.0215-17","article-title":"Peripheral ulcerative keratitis associated with granulomatosis with polyangiitisemerging despite cyclophosphamide, successfully treated with rituximab","author":"Fujita","year":"2018","journal-title":"Intern Med Tokyo Jpn"},{"key":"key-10.4103\/0301-4738.292595-21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11102-014-0592-7","article-title":"Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab","author":"Xu","year":"2015","journal-title":"Pituitary"},{"key":"key-10.4103\/0301-4738.292595-22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jbspin.2013.07.011","article-title":"Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis","author":"Caso","year":"2014","journal-title":"Joint Bone Spine"},{"key":"key-10.4103\/0301-4738.292595-23","first-page":"339","article-title":"Management of necrotizing scleritis after pterygium surgery with rituximab","author":"FidelixTS","year":"2016","journal-title":"Arq Bras Oftalmol"},{"key":"key-10.4103\/0301-4738.292595-24","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2005.075689","article-title":"Successful treatment of Wegener's granulomatosis associated scleritis with rituximab","author":"Cheung","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292595-25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000342842","article-title":"Combined infliximab and rituximab in necrotising scleritis","author":"Morarji","year":"2012","journal-title":"Case Rep Ophthalmol"},{"key":"key-10.4103\/0301-4738.292595-26","first-page":"223","article-title":"Rituximab treatment for persistent scleritis associated with rheumatoid arthritis","author":"Iaccheri","year":"2010","journal-title":"OculImmunolInflamm"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:52:45Z","timestamp":1786733565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_896_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"alternative-id":["292595"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_896_20","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}